Publications by authors named "Fatoumatta Kanuteh"
Article Synopsis
- Mass drug administration (MDA) with dihydroartemisinin-piperaquine (DP) was tested in a study to evaluate its effect on reducing malaria transmission in low-transmission areas.
- The study found that there was a significant drop in malaria infection rates and clinical cases in 2014 and 2015 compared to 2013, with a coverage rate of over 65% for the drug.
- However, individuals previously infected had a higher risk of reinfection post-MDA, and while the intervention was effective in many areas, it was less successful in eastern Gambia, suggesting that targeted and repeated MDA could enhance malaria control.
Over the last decades, malaria has declined substantially in The Gambia but its transmission has not been interrupted. In order to better target control interventions, it is essential to understand the dynamics of residual transmission. This prospective cohort study was conducted between June 2013 and April 2014 in six pairs of villages across The Gambia.
View Article and Find Full Text PDFBackground: MPT64 rapid speciation tests are increasingly being used in diagnosis of tuberculosis (TB). Mycobacterium africanum West Africa 2 (Maf 2) remains an important cause of TB in West Africa and causes one third of disease in The Gambia. Since the introduction of MPT64 antigen tests, a higher than expected rate of suspected non-tuberculous mycobacteria (NTM) was seen among AFB smear positive TB suspects, which led us to prospectively assess sensitivity of the MPT64 antigen test in our setting.
View Article and Find Full Text PDF